Breast cancer

Breast cancer
2020-12-20T00:00:00.000+08:00
Ongoing

EA1183

EA1183
Breast Cancer

FDG PET to Assess Therapeutic Response in Patients with Bone-dominant Metastatic Breast Cancer, FEATURE

FDG PET to Assess Therapeutic Response in Patients with Bone-dominant Metastatic Breast Cancer, FEATURE

Topic

EA1183

Disease

Breast cancer

Description

Primary Objective: Evaluate the performance of FDG-PET/CT response criteria (modified PERCIST complete, partial and stable metabolic disease versus progressive metabolic disease) as a binary predictor of PFS in patients with BD MBC treated with systemic therapy

Contact

Florida

Peggy Mouradian

Florida Peggy Mouradian ::: (954) 370-7555